HB Wealth Management LLC Increases Position in Sanofi (NASDAQ:SNY)

HB Wealth Management LLC lifted its stake in shares of Sanofi (NASDAQ:SNY - Free Report) by 151.8% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 15,496 shares of the company's stock after buying an additional 9,342 shares during the period. HB Wealth Management LLC's holdings in Sanofi were worth $747,000 as of its most recent SEC filing.

Other institutional investors also recently modified their holdings of the company. Northwest Investment Counselors LLC acquired a new position in shares of Sanofi during the third quarter worth $29,000. Concord Wealth Partners increased its holdings in Sanofi by 157.8% in the third quarter. Concord Wealth Partners now owns 593 shares of the company's stock valued at $34,000 after purchasing an additional 363 shares during the period. Fortitude Family Office LLC raised its position in Sanofi by 708.6% during the 3rd quarter. Fortitude Family Office LLC now owns 752 shares of the company's stock worth $43,000 after purchasing an additional 659 shares during the last quarter. Sunbelt Securities Inc. raised its position in Sanofi by 72.1% during the 3rd quarter. Sunbelt Securities Inc. now owns 747 shares of the company's stock worth $43,000 after purchasing an additional 313 shares during the last quarter. Finally, Versant Capital Management Inc bought a new position in Sanofi during the 4th quarter worth $54,000. 14.04% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Separately, StockNews.com lowered Sanofi from a "buy" rating to a "hold" rating in a research report on Thursday, December 12th. Two research analysts have rated the stock with a hold rating, one has issued a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, Sanofi presently has an average rating of "Moderate Buy" and a consensus target price of $57.50.

Sanofi Trading Down 0.3 %

NASDAQ:SNY traded down $0.18 during trading hours on Wednesday, hitting $51.51. 1,836,591 shares of the company were exchanged, compared to its average volume of 2,554,069. The company has a fifty day simple moving average of $48.49 and a 200 day simple moving average of $52.16. Sanofi has a one year low of $45.22 and a one year high of $58.97. The company has a current ratio of 1.00, a quick ratio of 0.65 and a debt-to-equity ratio of 0.17. The stock has a market capitalization of $130.72 billion, a price-to-earnings ratio of 26.28, a price-to-earnings-growth ratio of 1.25 and a beta of 0.57.

Sanofi (NASDAQ:SNY - Get Free Report) last posted its quarterly earnings data on Friday, October 25th. The company reported $1.57 earnings per share for the quarter, topping the consensus estimate of $0.22 by $1.35. Sanofi had a return on equity of 27.45% and a net margin of 9.96%. The firm had revenue of $13.44 billion during the quarter, compared to analyst estimates of $16.59 billion. During the same period last year, the company posted $2.55 EPS. The business's quarterly revenue was up 12.3% on a year-over-year basis. Sell-side analysts expect that Sanofi will post 3.92 EPS for the current fiscal year.

Sanofi Company Profile

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.